These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 15264244)
1. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244 [TBL] [Abstract][Full Text] [Related]
2. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS). O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431 [TBL] [Abstract][Full Text] [Related]
3. SELDI protein profiling of dunning R-3327 derived cell lines: identification of molecular markers of prostate cancer progression. Malik G; Rojahn E; Ward MD; Gretzer MB; Partin AW; Semmes OJ; Veltri RW Prostate; 2007 Oct; 67(14):1565-75. PubMed ID: 17705230 [TBL] [Abstract][Full Text] [Related]
4. Analysis of prostate cancer by proteomics using tissue specimens. Liu AY; Zhang H; Sorensen CM; Diamond DL J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032 [TBL] [Abstract][Full Text] [Related]
5. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. Geng X; Wang F; Li YG; Zhu GP; Zhang WM J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545 [TBL] [Abstract][Full Text] [Related]
6. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516 [TBL] [Abstract][Full Text] [Related]
7. [Screening of differentially expressed proteins associated with directional highly lymphatic metastasis in ovarian carcinoma cell lines using SELDI-TOF-MS technology]. Guan X; Li DR; Wang Q; Li L; Ruan HY; Zhang W Ai Zheng; 2008 Nov; 27(11):1155-60. PubMed ID: 19000445 [TBL] [Abstract][Full Text] [Related]
8. SELDI-TOF-MS of saliva: methodology and pre-treatment effects. Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117 [TBL] [Abstract][Full Text] [Related]
9. A data-analytic strategy for protein biomarker discovery: profiling of high-dimensional proteomic data for cancer detection. Yasui Y; Pepe M; Thompson ML; Adam BL; Wright GL; Qu Y; Potter JD; Winget M; Thornquist M; Feng Z Biostatistics; 2003 Jul; 4(3):449-63. PubMed ID: 12925511 [TBL] [Abstract][Full Text] [Related]
10. Biomarker profiling of plasma from acute coronary syndrome patients. Application of ProteinChip Array analysis. Florian-Kujawski M; Hussain W; Chyna B; Kahn S; Hoppensteadt D; Leya F; Fareed J Int Angiol; 2004 Sep; 23(3):246-54. PubMed ID: 15765039 [TBL] [Abstract][Full Text] [Related]
11. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221 [TBL] [Abstract][Full Text] [Related]
12. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model. Mohler JL; Levy F; Sharief Y Cancer Res; 1991 Dec; 51(24):6580-5. PubMed ID: 1742730 [TBL] [Abstract][Full Text] [Related]
13. Time course proteomic profile of rat acute myocardial infarction by SELDI-TOF MS analysis. Zhang G; Zhou B; Zheng Y; Feng K; Rao L; Zhang J; Xin J; Zhang B; Zhang L Int J Cardiol; 2009 Jan; 131(2):225-33. PubMed ID: 18180059 [TBL] [Abstract][Full Text] [Related]
14. Use of surface enhanced laser desorption/ionization-time of flight mass spectrometry (SELDI-TOF MS) to study protein expression in a rat model of cocaine withdrawal. Geng T; Seitz PK; Thomas ML; Xu B; Soman KV; Kurosky A; Luxon BA; Cunningham KA J Neurosci Methods; 2006 Nov; 158(1):1-12. PubMed ID: 16766040 [TBL] [Abstract][Full Text] [Related]
15. [Comparative proteomic analysis of human large cell lung cancer cell line with high and low metastasis potentials]. Gao LW; Zhu W; Feng ZH; An N Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):706-10. PubMed ID: 19024295 [TBL] [Abstract][Full Text] [Related]
16. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. Lund R; Leth-Larsen R; Jensen ON; Ditzel HJ J Proteome Res; 2009 Jun; 8(6):3078-90. PubMed ID: 19341246 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data. Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967 [TBL] [Abstract][Full Text] [Related]
18. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics. Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929 [TBL] [Abstract][Full Text] [Related]
19. Identification of protein biomarkers for schizophrenia and bipolar disorder in the postmortem prefrontal cortex using SELDI-TOF-MS ProteinChip profiling combined with MALDI-TOF-PSD-MS analysis. Novikova SI; He F; Cutrufello NJ; Lidow MS Neurobiol Dis; 2006 Jul; 23(1):61-76. PubMed ID: 16549361 [TBL] [Abstract][Full Text] [Related]
20. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS. Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]